Non Invasive Prenatal Testing Market

Non Invasive Prenatal Testing Market Size, Share, Growth Analysis, By Gestation Period(0-12 Weeks, 13-24 Weeks, 25-36 Weeks), By Pregnancy Risk(High & Average Risk, Low Risk), By Method(Ultrasound Detection, Biochemical Screening Tests, Cell-free DNA in Maternal Plasma Tests), By Technology(NGS, Array Technology, PCR, Others), By Product(Consumables & Reagents, Instruments), By Application(Trisomy, Microdeletion Syndrome, Other Applications), By End-use(Hospitals & Clinics, Diagnostic Laboratories), By Regional(North America, Europe, Asia Pacific, Latin America) - Industry Forecast 2025-2032


Report ID: UCMIG35A2459 | Region: Global | Published Date: Upcoming |
Pages: 165 | Tables: 55 | Figures: 60

Segmentation Analysis:

The Non Invasive Prenatal Testing Market is segmented by Gestation Period, Pregnancy Risk, Method, Technology, Product, Application, End-use, Regional. We are analyzing the market of these segments to identify which segment is the largest now and in the future, which segment has the highest growth rate, and the segment which offers the opportunity in the future.

Non Invasive Prenatal Testing Market Basis Point Share Analysis, 2021 Vs. 2028
BasisPointShareAnalysis
To get detailed analysis on all segments
BUY NOW
  • Based on Gestation Period the market is segmented as, 0-12 Weeks, 13-24 Weeks, 25-36 Weeks
  • Based on Pregnancy Risk the market is segmented as, High & Average Risk, Low Risk
  • Based on Method the market is segmented as, Ultrasound Detection, Biochemical Screening Tests, Cell-free DNA in Maternal Plasma Tests
  • Based on Technology the market is segmented as, NGS, Array Technology, PCR, Others
  • Based on Product the market is segmented as, Consumables & Reagents, Instruments
  • Based on Application the market is segmented as, Trisomy, Microdeletion Syndrome, Other Applications
  • Based on End-use the market is segmented as, Hospitals & Clinics, Diagnostic Laboratories
  • Based on Regional the market is segmented as, North America, Europe, Asia Pacific, Latin America
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

The market for Non Invasive Prenatal Testing was estimated to be valued at US$ XX Mn in 2021.

The Non Invasive Prenatal Testing Market is estimated to grow at a CAGR of XX% by 2028.

The Non Invasive Prenatal Testing Market is segmented on the basis of Gestation Period, Pregnancy Risk, Method, Technology, Product, Application, End-use, Regional.

Based on region, the Non Invasive Prenatal Testing Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.

The key players operating in the Non Invasive Prenatal Testing Market are Genesis Genetics (CooperSurgical, Inc.), Natera, Inc., Centogene N.V., Illumina, Inc. (Verinata Health, Inc.), Eurofins LifeCodexx GmbH, MedGenome Labs Ltd., F. Hoffmann-La Roche Ltd. (Ariosa Diagnostics), Myriad Women’s Health, Inc. (Counsyl, Inc.), Progenity, Inc., Qiagen, Laboratory Corp. of America Holdings, Quest Diagnostics, Inc..

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Non Invasive Prenatal Testing Market

Report ID: UCMIG35A2459

$5,300
BUY NOW GET FREE SAMPLE